The 'Squawk on the Street' team discuss Carl Icahn's decision to drop his fight with the Cigna-Express Scripts deal.
Carl Icahn dropped his fight against the Cigna-Express Scripts deal citing the crossover was too big.
CNBC's Leslie Picker reports on Glenview Capital's Larry Robbins letter to shareholders in support of the Cigna-Express Scripts deal.
Icahn's searing letter opposing Cigna's $54 billion acquisition of pharmacy benefit manager Express Scripts says the "folly ... may well become one of the worst blunders in corporate history."
David Cordani, Cigna CEO, discusses the company's deal for Express Scripts and investor Carl Icahn's open letter to shareholders against it.
The "Squawk on the Street" news team discusses Carl Icahn's letter to Cigna shareholders about the company's plan to acquire Express Scripts.